Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jamie Dimon Met Yellen On First Republic

-Bloomberg
byBill Haddad
March 16, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

-Bloomberg

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Syndax Presents Data From Pivotal AUGMENT-101 Trial Of Revumenib In Relapsed/Refractory KMT2Ar Acute Leukemia At Oral Presentation During ASH Meeting; Trial Met Its Primary Endpoint At Interim Analysis Of The Pooled KMT2Ar AML And ALL Cohorts

By Benzinga Newsdesk
December 12, 1:04 PM
– Pivotal AUGMENT-101 trial met its primary endpoint at interim analysis of the pooled KMT2Ar AML and ALL cohorts (p-value = 0.0036); CR/CRh rate consistent across adult and pediatric patients –– 63% overall response

SNDX

Read More

Sagimet Biosciences Announces Completion Of Enrollment Of 120 Patients For Phase 3 Clinical Trial By Its Partner Ascletis Of Denifanstat Combined With Bevacizumab For Treatment Of Recurrent Glioblastoma

By Benzinga Newsdesk
September 27, 4:09 PM
Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, today announced that its license partner, Ascletis Bioscience

SGMT